Vaccine Safety Across Ages & Platforms

Moderator(s)

• 

  Catherine Cohet, PhD (she/her/hers)

  Pharmacoepidemiology/RWE Senior Specialist
  RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency
  Amsterdam, Netherlands
• 

  Amie Goodin, PhD, MPP

  Assistant Professor
  Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States, United States

  Slides

Presentations:

• 1:30 PM – 1:45 PM CEST

  Comparing Safety and Effectiveness of Pfizer BA.4-5 and Sanofi bivalent COVID-19 Vaccines Used in the Spring 2023 Booster Programme in England: a Target Trial Emulation Study Using the OpenSAFELY Platform
  

  Presenting Author: William Hulme, MSc PhD (he/him/his) – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Colm Andrews – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Em Prestige – London School of Hygiene and Tropical Medicine

  Co-Author: Edward Parker – London School of Hygiene and Tropical Medicine

  Co-Author: Venexia M. Walker, PhD – University of Bristol

  Co-Author: Christopher Wood – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Becky Smith – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Andrea Schaffer – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Alex Walker – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Helen Curtis – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Brian MacKenna – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford

  Co-Author: Amir Mehrkar – University of Oxford

  Co-Author: Ben Goldacre – University of Oxford

  Co-Author: Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet

  Co-Author: Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol
• 1:45 PM – 2:00 PM CEST

  Influence of mRNA Covid-19 Vaccine Dosing Interval on the Risk of Myocarditis
  

  Presenting Author: Stéphane Le Vu – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Marion Bertrand – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Laura Semenzato, MSc (she/her/hers) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
• 2:00 PM – 2:15 PM CEST

  Risk of Facial Palsy Following COVID-19 Vaccination: A Nationwide Large-Linked Database Study
  

  Co-Author: Dongwon Yoon, PharmD, PhD (he/him/his) – National Institute on Aging, National Institutes of Health

  Presenting Author: Kyungyeon Jung, PharmD – Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea

  Co-Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

  Co-Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

  Co-Author: Byeol-A Yoon, MD – Department of Neurology, Dong-A University College of Medicine, Busan, South Korea

  Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
• 2:15 PM – 2:30 PM CEST

  Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 Years
  

  Presenting Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

  Co-Author: Elizabeth R. Smith – Acumen, LLC

  Co-Author: Zhiruo Wan, MS – Acumen LLC

  Co-Author: Kandace L. Amend, PhD – Optum Epidemiology

  Co-Author: Alex Secora, PhD – IQVIA

  Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health

  Co-Author: Kamran Kazemi – Acumen, LLC

  Co-Author: Jennifer Song, MA, MURP – United Health Group

  Co-Author: Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc

  Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health

  Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

  Co-Author: Nandini Selvam, PhD, MPH – IQVIA

  Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health

  Co-Author: Mao I. Hu, BS – Acumen LLC

  Co-Author: Yoganand Chillarige, MPA – Acumen LLC

  Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
• 2:30 PM – 2:45 PM CEST

  Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older
  

  Co-Author: Xiangyu (Chianti) Shi, MS – Acumen LLC

  Presenting Author: Joann F. Gruber, PhD, MSPH – US FDA

  Co-Author: Michelle Ondari, MSPH – Acumen LLC

  Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration

  Co-Author: Pablo Freyria Duenas, MA – Acumen LLC

  Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA

  Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC

  Co-Author: Sylvia Cho, PhD – US FDA

  Co-Author: Laurie Feinberg, MD – Acumen LLC

  Co-Author: Mao I. Hu, BS – Acumen LLC

  Co-Author: Yoganand Chillarige, MPA – Acumen LLC

  Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA

  Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

  Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration

  Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
• 2:45 PM – 3:00 PM CEST

  Rotavirus vaccine safety surveillance using a tree‐temporal scan statistic signal-detection method
  

  Presenting Author: Na-Young Jeong, PhD – Ewha Womans University

  Co-Author: Haerin Cho, MA – Ewha Womans University

  Co-Author: Hee-Jin Kim, MA – Ewha Womans University

  Co-Author: Nam-Kyong Choi – Ewha Womans University